Fentanyl Drip for Comfort Measures in Dying Patients

Benefits of Fentanyl for End-of-Life Care

Fentanyl is highly effective for managing both pain and dyspnea, which are common distressing symptoms in terminally ill patients, according to the National Comprehensive Cancer Network 2, 3
The American College of Physicians and other medical societies suggest that, unlike morphine and codeine, fentanyl has no active metabolites, making it safer for patients with renal impairment who are often encountered in end-of-life scenarios 1, 4
Fentanyl is also preferred in patients with liver failure, though its half-life may be prolonged with repeated dosing or high doses, as noted by the European Association for Palliative Care 1, 5
The absence of histamine release with fentanyl provides hemodynamic stability, which is particularly important in fragile dying patients, as recommended by the American Heart Association 1, 4

For dying patients, continuous IV infusion allows for rapid titration and steady pain control, with an initial dose of 25-50 μg administered slowly over 1-2 minutes, especially in elderly or debilitated patients, as suggested by the European Society of Intensive Care Medicine 6, 4
Initial therapy should involve rapid titration with small incremental IV doses, with a dosing range of 25-300 μg/hour based on patient response, according to the American Society of Health-System Pharmacists 4

When managing dyspnea in dying patients, low doses of fentanyl titrated to the patient's response are effective, as recommended by the National Institute for Health and Care Excellence 2, 3
For patients unable to self-report symptoms, observe for pain-related behaviors and respiratory distress to guide dosing, as suggested by the American Academy of Hospice and Palliative Medicine 6
In dying patients, opioid doses should not be reduced solely for decreased blood pressure, respiration rate, or level of consciousness when necessary for adequate symptom management, according to the European Association for Palliative Care 3

Institute a bowel regimen with stimulant or osmotic laxative in all patients receiving sustained opioid administration unless contraindicated, as recommended by the American Gastroenterological Association 1, 9
Monitor for respiratory depression, though this concern is typically balanced against comfort goals in actively dying patients, as noted by the American Thoracic Society 7, 8

Fentanyl causes less constipation than oral morphine, improving patient comfort, and is relatively safe in renal failure since it has no active metabolites, unlike morphine, codeine, and hydromorphone, as suggested by the Kidney Disease: Improving Global Outcomes initiative 1, 7
For patients who develop myoclonus on other opioids, rotating to fentanyl may reduce this side effect, according to the American Academy of Neurology 1